There is a need for effective non-surgical treatment options in patients with non-muscle invasive bladder cancer (NMIBC) in whom Bacillus Calmette-Guerin (BCG) therapy has failed. We aimed to determine the efficacy of Electromotive Drug Administration (EMDA) of mitomycin C (MMC) in BCG unresponsive patients.
MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE / Juvet*, Tristan; Wallis, Christopher; Krimus, Lior; Kuk, Cynthia; Erlich, Annette; Mari, Andrea; Kulkarni, Girish; Fleshner, Neil; Zlotta, Alexandre. - In: THE JOURNAL OF UROLOGY. - ISSN 0022-5347. - ELETTRONICO. - 203:(2020), pp. e1121-e1121. [10.1097/JU.0000000000000959.01]
MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE
Mari, Andrea;
2020
Abstract
There is a need for effective non-surgical treatment options in patients with non-muscle invasive bladder cancer (NMIBC) in whom Bacillus Calmette-Guerin (BCG) therapy has failed. We aimed to determine the efficacy of Electromotive Drug Administration (EMDA) of mitomycin C (MMC) in BCG unresponsive patients.File | Dimensione | Formato | |
---|---|---|---|
JU.0000000000000959.01.pdf
Accesso chiuso
Descrizione: Articolo principale
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
43.17 kB
Formato
Adobe PDF
|
43.17 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.